ATA Guidelines Tools

Hyperthyroidism

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/751899

Contents of this Issue

Navigation

Page 2 of 33

3 Determination of Etiology Table 1. Causes of Thyrotoxicosis Thyrotoxicosis associated with a normal or elevated radioactive iodine (RAI) uptake over the neck a GD TA or TMNG Trophoblastic disease yroid-stimulating hormone (TSH)-producing pituitary adenomas Resistance to thyroid hormone (T 3 receptor β mutation [THRB]) b Thyrotoxicosis associated with a near-absent RAI uptake over the neck Painless (silent) thyroiditis Amiodarone-induced thyroiditis Subacute (granulomatous, de Quervain's) thyroiditis Palpation thyroiditis Iatrogenic thyrotoxicosis Factitious ingestion of thyroid hormone Struma ovarii Acute thyroiditis Extensive metastases from follicular thyroid cancer a In iodine-induced or iodine-exposed hyperthyroidism (including amiodarone type 1), the uptake may be low. b Patients are not uniformly clinically hyperthyroid. Determination of Etiology 1. The etiology of thyrotoxicosis should be determined. If the diagnosis is not apparent based on the clinical presentation and initial biochemical evaluation, diagnostic testing is indicated and can include, depending on available expertise and resources: (S-M) 1. measurement of thyrotropin receptor antibodies (TRAb) 2. determination of the radioactive iodine uptake (RAIU) or 3. measurement of thyroidal blood flow on ultrasonography. • An 123 I or 99m Tc pertechnetate scan should be obtained when the clinical presentation suggests a toxic adenoma or toxic multinodular goiter.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Hyperthyroidism